Abstract
Mutation and polymorphism data for Hirschsprung disease (HSCR) varies among ethnic groups. Single nucleotide polymorphisms (SNP) of RET proto-oncogene (RET) were recently shown to be associated with the disease, and with disease severity, in different populations. In this study, comprehensive analysis of RET, GDNF, EDNRB, ET-3, and SOX-10 genes among sporadic HSCR in Thailand was conducted by standard PCR-SSCP, RFLP, and sequencing methods. Of 41 patients, 30 cases had rectosigmoid disease (RSD) and 11 cases were assigned to the long-segment disease (LSD) group. Four missense mutations of RET, S100M, R231H, T278N, and G533S, were identified in three patients. One novel missense mutation, V111Q, was detected in EDNRB. For ET-3, two novel missense mutations, D166E and C173R, occurred concomitantly in a patient. The incidence of missense mutation was significantly higher in our female HSCR patient than in the male counterpart. Statistical analysis of the SNPs revealed a significant difference between allele distribution of RET L769L in patients in the LSD and RSD groups. The predominant genotype construct of RET A45A/L769L in our HSCR was GG/GG, which is obviously different from results from all previous studies. The GG/GG genotype construct was associated with RSD and with males. The study also detected a variant allele of RET S836S which has never been reported in Asian cohorts.
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Amiel J, Lyonnet S (2001) Hirschsprung disease, associated syndromes, and genetics: a review. J Med Genet 38:729–739
Borrego S, Saez ME, Ruiz A, Gimm O, Lopez-Alonso M, Antinolo G, Eng C (1999) Specific polymorphisms in the RET proto-oncogene are over-represented in patients with Hirschsprung disease and may represent loci modifying phenotypic expression. J Med Genet 36:771–774
Borrego S, Ruiz A, Saez ME, Gimm O, Gao X, Lopez-Alonso M, Hernandez A, Wright FA, Antinolo G, Eng C (2000) RET genotypes comprising specific haplotypes of polymorphic variants predispose to isolated Hirschsprung disease. J Med Genet 37:572–578
Fucharoen S, Fucharoen G, Sriroongrueng W, Laosombat V, Jetsrisuparb A, Prasatkaew S, Tanpaichitr VS, Suvatte V, Tuchinda S, Fukumaki Y (1989) Molecular basis of beta-thalassemia in Thailand: analysis of beta-thalassemia mutations using the polymerase chain reaction. Hum Genet 84:41–46
Garcia-Barcelo MM, Sham MH, Lui VCH, Chen BLS, Song YQ, Lee WS, Yung SK, Romeo G, Tam PKH (2003) Chinese patients with sporadic Hirschsprung’s disease are predominantly represented by a single RET haplotype. J Med Genet 40:122
Garcia-Barcelo M, Sham MH, Lee WS, Lui VC, Chen BL, Wong KK, Wong JS, Tam PK (2004) Highly recurrent RET mutations and novel mutations in genes of the receptor tyrosine kinase and endothelin receptor B pathways in Chinese patients with sporadic Hirschsprung disease. Clin Chem 50:93–100
Griseri P, Sancandi M, Patrone G, Bocciardi R, Hofstra R, Ravazzolo R, Devoto M, Romeo G, Ceccherini I (2000) A single-nucleotide polymorphic variant of the RET proto-oncogene is underrepresented in sporadic Hirschsprung disease. Eur J Hum Genet 8:721–724
Griseri P, Pesce B, Patrone G, Osinga J, Puppo F, Sancandi M, Hofstra R, Romeo G, Ravazzolo R, Devoto M, Ceccherini I (2002) A rare haplotype of the RET proto-oncogene is a risk-modifying allele in Hirschsprung disease. Am J Hum Genet 71:969–974
Inoue M, Hosoda K, Imura K, Kamata S, Fukuzawa M, Nakao K, Okada A (1998) Mutational analysis of the endothelin-B receptor gene in Japanese Hirschsprung’s disease. J Pediatr Surg 33:1206–1208
Kusafuka T, Puri P (1997) The RET proto-oncogene: a challenge to understanding of disease pathogenesis. Pediatr Surg Int 12:11–18
Kusafuka T, Puri P (1998) Genetic aspects of Hirschsprung’s disease. Semin Pediatr Surg 7:148–155
Kusafuka T, Wang Y, Puri P (1997) Mutation analysis of the RET, the endothelin-B receptor, and the endothelin-3 genes in sporadic cases of Hirschsprung’s disease. J Pediatr Surg 32:501–504
Laosombat V, Fucharoen SP, Panich V, Fucharoen G, Wongchanchailert M, Sriroongrueng W, Nopparatana C, Kenpitak K, Maipang M, Fukumaki Y (1992) Molecular basis of beta thalassemia in the south of Thailand. Am J Hematol 41:194–198
Martuciello G, Checcherini I, Lerone M, Jasonni V (2000) Pathogenesis of Hirschsprung’s disease. J Pediatr Surg 35:1017–1025
Pingault V, Bonduran N, Kuhlbrodt K, Goerich DE, Prehu MO, Puliti A, Herbarth B, Hermans-Borgmeyer I, Legius E, Matthijs G, Amiel J, Lyonnet S, Ceccerini I, Romeo G, Smith JC, Read AP, Wegner M, Goosens M (1998) SOX10 mutations in patients with Waardenburg–Hirschsprung disease. Nat Genet 18:171–173
Puri P, Shinkai T (2004) Pathogenesis of Hirschsprung’s disease and its variants: recent progress. Semin Pediatr Surg 13:18–24
Sakai T, Nirasawa Y, Itoh Y, Wakizaka A (2000) Japanese patients with sporadic Hirschsprung: mutation analysis of the receptor tyrosine kinase proto-oncogene, endothelin-B receptor, endothelin-3, glial cell line-derived neurotrophic factor and neurturin genes: a comparison with similar studies. Eur J Pediatr 159:160–167
Sancandi M, Griseri P, Pesce B, Patrone G, Puppo F, Lerone M, Martuciello G, Romeo G, Ravazzolo R, Devoto M, Ceccherini I (2003) Single nucleotide polymorphic alleles in the 5′ region of the RET proto-oncogene define a risk haplotype in Hirschsprung’s disease. J Med Genet 40:714–718
Sangkhathat S, Chiengkriwate P, Kusafuka T, Patrapinyokul S, Fukuzawa M (2005) Novel mutation of endothelin-B receptor gene in Waardenburg–Hirschsprung disease. Pediatr Surg Int 21:960–963
Tam PKH, Garcia-Barcelo M (2004) Molecular genetics of Hirschsprung’s disease. Semin Pediatr Surg 13:236–248
Tou JF, Li MJ, Guan T, Li JC, Zhu XK, Feng ZG (2006) Mutation of RET proto-oncogene in Hirschsprung’s disease and intestinal neuronal dysplasia. World J Gastroenterol 12:1136–1139
Wu TT, Tsai TW, Chu CT, Lee ZF, Hung CM, Su CC, Li SY, Hsieh M, Li C (2005) Low RET mutation frequency and polymorphism analysis of the RET and EDNRB genes in patients with Hirschsprung disease in Taiwan. J Hum Genet 50:168–174
Acknowledgments
The study was partially supported by a grant-in-aid from the Ministry of Education, Sciences, Sports and Culture of Japan (Grant no.6591785). The authors wish to thank Kritsana Domdee, who established our biological banking system and Pornprot Limprasert, MD, PhD for his suggestion in data analysis.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sangkhathat, S., Kusafuka, T., Chengkriwate, P. et al. Mutations and polymorphisms of Hirschsprung disease candidate genes in Thai patients. J Hum Genet 51, 1126–1132 (2006). https://doi.org/10.1007/s10038-006-0064-7
Received:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1007/s10038-006-0064-7
Keywords
This article is cited by
-
Mutations in Smad-interacting protein 1 gene are responsible for absence of its expression in Hirschsprung’s disease
Clinical and Experimental Medicine (2018)
-
RET and EDNRB mutation screening in patients with Hirschsprung disease: Functional studies and its implications for genetic counseling
European Journal of Human Genetics (2016)
-
RET gene is a major risk factor for Hirschsprung’s disease: a meta-analysis
Pediatric Surgery International (2015)
-
The rare intracellular RET mutation p.S891A in a Chinese Han family with familial medullary thyroid carcinoma
Journal of Biosciences (2014)
-
Correlation between multiple RET mutations and severity of Hirschsprung’s disease
Pediatric Surgery International (2013)
